| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |